Skip to main content
Springer Nature Link
Log in

Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Agents?

  • Chapter
Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA

Part of the book series: Topics in the Neurosciences ((TNSC,volume 9))

Abstract

It has been hypothesized that MDMA and substances that possess a psychopharmacological effect similar to MDMA are members of a novel pharmacological class named entactogens [1–3]. In this chapter evidence will be presented to support this, through a discussion of the data acquired in efforts directed toward testing this hypothesis. Although these studies are far from complete, the results gathered thus far, together with those from other laboratories, support the view that the pharmacology of entactogens is clearly different from other known classes of compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+
from €39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 160.49
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
EUR 213.99
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

') var buybox = document.querySelector("[data-id=id_"+ timestamp +"]").parentNode var buyingOptions = buybox.querySelectorAll(".buying-option") ;[].slice.call(buyingOptions).forEach(initCollapsibles) var buyboxMaxSingleColumnWidth = 480 function initCollapsibles(subscription, index) { var toggle = subscription.querySelector(".buying-option-price") subscription.classList.remove("expanded") var form = subscription.querySelector(".buying-option-form") var priceInfo = subscription.querySelector(".price-info") var buyingOption = toggle.parentElement if (toggle && form && priceInfo) { toggle.setAttribute("role", "button") toggle.setAttribute("tabindex", "0") toggle.addEventListener("click", function (event) { var expandedBuyingOptions = buybox.querySelectorAll(".buying-option.expanded") var buyboxWidth = buybox.offsetWidth ;[].slice.call(expandedBuyingOptions).forEach(function(option) { if (buyboxWidth buyboxMaxSingleColumnWidth) { toggle.click() } else { if (index === 0) { toggle.click() } else { toggle.setAttribute("aria-expanded", "false") form.hidden = "hidden" priceInfo.hidden = "hidden" } } }) } initialStateOpen() if (window.buyboxInitialised) return window.buyboxInitialised = true initKeyControls() })()

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Nichob. D.E., Hoffman. A.J. Obetlender. R.A., Jacob III. P., and Shulgin. A T., 1986 Derivatives of Hl.3-bemodioxol-5-yl)-2-butaiiainMe: Representatives of a rove! therapeutic class. J. Med. Chein. 29: 2009–2015.

    Article  Google Scholar 

  2. Nichols. D.E. 1986 Differences between the mechanisms of action of MDV.A. MBDB. and the classical hallucinogens. Identification of a new therapeutic class: Entactogens. J. Psychoactive Drugs 18: 305–313.

    PubMed  Google Scholar 

  3. Oberlender. R and Nichob. D.E., 1988 Drug discrimination studies with MDMA and amphetamine. Psychophatmacology 95: 71–76.

    Google Scholar 

  4. Jaffe. J.H., 1985. Drug addiction and drug abuse. In The Pharmacological Basis of Therapeutics, Seventh Edition. (Gilnun. A G., Goodman. L.S., Rail. T.W. Murad. F. cds). New York. MacmilLan Publishing Company, pp. 523–581

    Google Scholar 

  5. Werner. N., 1980. Norepinephrine, epinephrine, and the sypalhominietic amines. In The Pharmacological Basis of Therapeutics, Sixth Edition, ( Gilrnan, A.G., Gooiman. L.S. and Gilman. A., cds.) New York: Macmillan. pp 138–175

    Google Scholar 

  6. Greer. G. and Tolbcrt. R., 1986 Subjective reports of the effects of MDMA in a clinical setting. J. Psychoactive Drugs 18: 319–327.

    Google Scholar 

  7. Stolerman. I P. and D’Mello G.D. 1981 Role of training conditions in dsenmination of central nervous system stimulants by rats. Psychopharnuoology 73: 295–303.

    Article  Google Scholar 

  8. Barry. H., 1974 Classification of drugs according to their discriminate effects in rats. Fed. Proc. 33: 1814–1824.

    PubMed  Google Scholar 

  9. Overton. D.A., (1984). State dependent learning and drug discrimuiatioits In HanJkodt of PyHhopharmHelegy. Vol. 18 (lvcrsen. L.L., Ivcrscn. S.D and Snyder. S.H.cds.) New York: Plenum Press, pp. 59–126

    Google Scholar 

  10. Weil. A., 1976 The love drug. J. Psychoactive Drugs 8: 335–337

    Google Scholar 

  11. Turek. I S., Soskiri. R A. and Kurland. A A., 1974 Meihyleitedioxyamphctainine (MDA) Subjective effects J Psychedelic Dnigs 6:7–14128 7. Structure-Activity Relationships of MDMA and Related Compounds

    Google Scholar 

  12. Shannon, H.E., 1980. MDA and DOM: Substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat. Psychopharnucology 67: 311–312.

    Article  CAS  Google Scholar 

  13. Glennon, R.A., Rosccrans. J A., and Young, R. 1981 Behavioral properties of psychoactive phcnylisopiopylainincs in ran Eur J Pharmacol. 76: 353–360.

    Article  PubMed  CAS  Google Scholar 

  14. Glctinon. R.A. and Young. R., 19R4. MDA: An agent that produces stimulus effects similar to those of 3.4-DMA. LSD and cocaine. Fair. J. Pharmacol. 99: 249–250.

    Google Scholar 

  15. Glennon. R.A and Young. R., 1984. MDA: A psychoactive agent with dual stimulus effects. Life So. 34: 379–383

    Google Scholar 

  16. Shulgui. A.T., 1978. Psychotomimetic drugs Structure-activity relationships. In Handbook of Psychopharmacology. Vol 11 (lversen, L.L., lversen, S I), and Snyder. S.H., eds.). New York: Plenum, pp. 243–333.

    Google Scholar 

Download references

Authors
  1. David F. Nichols
    View author publications

    Search author on:PubMed Google Scholar

  2. Robert Oberlender
    View author publications

    Search author on:PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Stanford University Medical Center, USA

    Stephen J. Peroutka

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Nichols, D.F., Oberlender, R. (1990). Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Agents?. In: Peroutka, S.J. (eds) Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Topics in the Neurosciences, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1485-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1485-1_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8799-5

  • Online ISBN: 978-1-4613-1485-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics